Qualifying Notice for Gavreto

Name: Qualifying Notice for Gavreto
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

This Notice of Compliance with Conditions Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document: Notice of Compliance with Conditions (NOC/c), is to advise you that information submitted in support of the New Drug Submission for Gavreto (pralsetinib), Control Number 243731, for the indication of the treatment of adult patients with rearranged during transfection (RET) fusion-positive locally advanced unresectable or metastatic non-small cell lung cancer (NSCLC).

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-11-01

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Qualifying Notice for Gavreto (English, HTML) HTML
Qualifying Notice for Gavreto (French, HTML) HTML

Related open data

Health Canada